{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "August 2021: 68-year-old male presented with epigastric pain. Abdominal CT showed a space-occupying lesion in the body of the pancreas. Enhanced CT scans of the chest and pelvis showed no abnormalities. Preoperative carbohydrate antigen 19-9 (CA199) levels were significantly elevated at 798.7 U/ml (normal range, 0-27 U/ml).",
        "clinical_data": {
          "HPI": [
            {
              "summary": "68-year-old male presented with epigastric pain in August 2021.",
              "onset": "2021-08",
              "associated_symptoms": [
                "Epigastric pain"
              ]
            }
          ],
          "imaging": [
            {
              "type": "Space-occupying lesion",
              "body_part": "Pancreas body",
              "modality": "CT",
              "date": "2021-08"
            },
            {
              "modality": "CT",
              "body_part": "Chest",
              "finding": "no abnormalities",
              "date": "2021-08"
            },
            {
              "modality": "CT",
              "body_part": "Pelvis",
              "finding": "no abnormalities",
              "date": "2021-08"
            }
          ],
          "labs": [
            {
              "test": "Carbohydrate antigen 19-9",
              "value": "798.7",
              "unit": "U/ml",
              "flag": "abnormal",
              "reference_range": "0-27 U/ml",
              "timestamp": "2021-08"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient underwent laparoscopic radical pancreatic body-tail resection and splenectomy. Postoperative pathology confirmed moderately differentiated ductal adenocarcinoma (pT3N0M0). R0 resection was achieved.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Laparoscopic radical pancreatic body-tail resection",
              "approach": "laparoscopic",
              "date": null,
              "location": "pancreatic body-tail",
              "performed_by": null,
              "outcome": null
            },
            {
              "name": "Splenectomy",
              "approach": "laparoscopic",
              "date": null,
              "location": "spleen",
              "performed_by": null,
              "outcome": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "moderately differentiated ductal adenocarcinoma",
              "status": "active",
              "onset_date": null
            }
          ],
          "imaging": [],
          "medications": [],
          "vitals": [],
          "labs": [],
          "HPI": [],
          "ROS": [],
          "functional_status": [],
          "mental_status": [],
          "social_history": [],
          "allergies": []
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Patient declined chemotherapy and other treatments and asked for routine follow-up to monitor the lesion.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Chemotherapy",
              "outcome": "refused"
            },
            {
              "name": "Other treatments",
              "outcome": "refused"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "timestamp": "2022-05",
        "content": "Patient progressed with the development of a posterior cardiac annular nodule (1.7x1.3 cm). CA199 was 35.73 U/ml.",
        "clinical_data": {
          "labs": [
            {
              "test": "CA 19-9 antigen",
              "value": "35.73",
              "unit": "U/ml"
            }
          ],
          "diagnoses": [
            {
              "code": "C0439521",
              "label": "Cardiac nodule",
              "status": "active"
            }
          ],
          "imaging": [
            {
              "type": "Nodule",
              "body_part": "Heart",
              "finding": "posterior cardiac annular nodule (1.7x1.3 cm)"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "timestamp": "2022-08",
        "content": "Upper abdominal CT showed growth of the posterior cardiac annular nodule to 2.3x2.8 cm. CA199 level spiked to 124.8 U/ml. Patient diagnosed with recurrent metastatic pancreatic ductal adenocarcinoma (PDAC) and had an Eastern Cooperative Oncology Group (ECOG) score of 1.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Posterior cardiac annular nodule",
              "body_part": "Abdomen",
              "modality": "CT",
              "finding": "Growth of the posterior cardiac annular nodule to 2.3x2.8 cm"
            }
          ],
          "labs": [
            {
              "test": "CA199",
              "value": "124.8",
              "unit": "U/ml",
              "flag": "abnormal"
            }
          ],
          "diagnoses": [
            {
              "code": "C0678222",
              "label": "Recurrent metastatic pancreatic ductal adenocarcinoma",
              "status": "active"
            }
          ],
          "functional_status": [
            {
              "domain": "general",
              "description": "Eastern Cooperative Oncology Group (ECOG) score of 1",
              "score": "1",
              "scale": "ECOG"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient underwent four cycles of combination therapy, resulting in the disappearance of the posterior cardia lesion.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Combination therapy",
              "outcome": "Disappearance of posterior cardia lesion"
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "After 20 cycles of combination therapy, no tumor relapse was observed.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0027051",
              "label": "Neoplasm",
              "status": "resolved"
            }
          ],
          "procedures": [
            {
              "name": "C0009451",
              "outcome": "C0239901"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Next-generation sequencing (NGS) identified a BRCA2 mutation, microsatellite stability (MSS), a tumor mutational burden (TMB) of 5.76 Muts/Mb and PD-L1 negativity. Patient was initiated on a treatment regimen comprising of anlotinib (10 mg, days 1-14; 7 days off; 21-day cycle) and tislelizumab (200 mg, day 1; 20 days off; 21-day cycle).",
        "clinical_data": {
          "labs": [
            {
              "test": "Tumor Mutational Burden",
              "value": "5.76",
              "unit": "Muts/Mb"
            }
          ],
          "medications": [
            {
              "drug": "anlotinib",
              "dosage": "10 mg",
              "frequency": "days 1-14; 7 days off; 21-day cycle",
              "modality": "oral"
            },
            {
              "drug": "tislelizumab",
              "dosage": "200 mg",
              "frequency": "day 1; 20 days off; 21-day cycle",
              "modality": "IV"
            }
          ],
          "diagnoses": [
            {
              "code": "BRCA2",
              "label": "BRCA2 mutation",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Following four cycles of combination therapy, the patient achieved a complete response (CR), with total tumor disappearance.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0027051",
              "label": "Complete remission",
              "status": "resolved"
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "timestamp": "2023-11",
        "content": "Patient continued treatment regimen without adverse effects and remains on the regimen. Abdominal CT scans indicate complete response (CR) with a progression-free survival (PFS) duration of 14 months.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "abdomen",
              "modality": "CT",
              "finding": "complete response",
              "impression": "complete response"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Transition from initial presentation with epigastric pain and pancreatic lesion to undergoing surgical resection.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0030320",
            "C0205879"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Decision point after surgery where the patient declines chemotherapy and opts for monitoring.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C0009371"
          ],
          "change_type": "discontinuation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Disease progression with the development of a cardiac nodule and elevated CA199 levels.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0439521"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis",
          "timestamp": "2022-05"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Further disease progression with growth of the cardiac nodule, a spike in CA199, and diagnosis of recurrent metastatic PDAC.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0282697"
          ],
          "change_type": "escalation",
          "target_domain": "lab",
          "timestamp": "2022-08"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Initiation of combination therapy leading to the disappearance of the cardiac lesion.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Continued combination therapy with no tumor relapse observed.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "other",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Identification of BRCA2 mutation and initiation of anlotinib and tislelizumab regimen.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0006122",
            "C0009451"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Patient achieves complete response after four cycles of combination therapy.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "other",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N9",
      "to": "N10",
      "data": {
        "edge_id": "I_to_J",
        "branch_flag": true,
        "content": "Patient continues treatment regimen with complete response and progression-free"
      }
    }
  ]
}